Citation

Avy Violari, IMPAACT P1106 team, Mark F. Cotton, Mae Cababasay, Jiajia Wang, Ruth Mathiba, Lubbe Wiesner, Andrew Wiznia, Pearl Samson, Renee Browning, Jack Moye, Firdose L. Nakwa, Bobbie Graham, Eric Decloedt, Helena Rabie, Adrie Bekker, Mark Mirochnick, Edmund V. Capparelli, Tim R. Cressey. Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation study. Lancet HIV. 2022. PMID: 27936233

Citation

Belén P. Solans, Mark F. Cotton, Mark Mirochnick, Avy Violari, Jiajia Wang, Mae Cababasay, Lubbe Wiesner, Renee Browning, Jack Moye, Edmund V. Capparelli, Radojka M. Savic, Agathe Béranger, Adrie Bekker. Influence of NAT2 genotype and maturation on isoniazid exposure in low-birth-weight and preterm infants with or without HIV exposure. Clinical Infectious Diseases. 2022. PMID: 35134861

Citation

Esaú C João, Sheila M. Styrchak, Samantha R. Hardy, Jackson J. Wallner, Ross S. Milne, R. Leavitt Morrison, David Shapiro, Mark Mirochnick, Lisa M. Frenkel, Ceejay L. Boyce, Ingrid A. Beck. Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term. PLoS One. 2022. 17: e0275254. PMID: 36166463

Citation

Geraldo Duarte, Alice Stek, Avy Violari, Cristina B. Hofer, Jaime G. Deville, James Samwel Ngocho, José Henrique Pilotto, Mario Dias Correa Jr., David E. Shapiro, Trevon L. Fuller, Nahida Chakhtoura, Mark Mirochnick, Esaú C. João, Conrado Milani Coutinho, Meredith G. Warshaw. Effects of Initiating Raltegravir-Based Versus Efavirenz-Based Antiretroviral Regimens During Pregnancy on Weight Changes and Perinatal Outcomes: NICHD P1081. Journal of Acquired Immune Deficiency Syndromes. 2022. 91: 403-409. PMID: 36049477

Citation

Sharon Nachman, Nicole S Sampson, Xinxin Yang, Matthew F Wipperman. Exploring the value of Mycobacterium tuberculosis modified lipoprotein as a potential biomarker for TB detection in children. BMC Infectious Diseases. 2022. 22: 158. PMID: 35177035

Citation

Angela Colbers, Françoise Renaud, Alexandra Calmy, Polly Clayden, Marissa Vicari, Imelda C Mahaka, Jennifer M Zech, Cadi Irvine, Elaine J Abrams, Participants of the WHO-IMPAACT Workshop “Approaches to Enhance and Accelerate Study of New Drugs for HIV and Associated Infections in Pregnant Women”, Martina Penazzato, Shahin Lockman. Accelerating investigation of new HIV drugs in pregnancy: advancing the research agenda from theory to action. Journal of the International AIDS Society. 2022. 25: e25912. PMID: 35851834

Citation

S Kim, L Naini, J Shenje, E Mitchell, M Raesi, M Lourens, A Mendoza, F Conradie, N Suryavanshi, M Hughes, S Shah, G Churchyard, S Swindells, A Hesseling, V Rouzier, A Gupta, M Murrill. Caregiver willingness to give TPT to children living with drug-resistant TB patients. International Journal of Tuberculosis and Lung Disease. 2022. 26: 949-955. PMID: 36163664

Citation

Camlin Tierney, Sharon Huang, Marion Peters, Tsungai Chipato, Frances Martinson, Neaka Mohtashemi, Dingase Dula, Kathy George, Nahida Chaktoura, Karin L Klingman, Devasena Gnanashanmugam, Judith S Currier, Mary G Fowler, Debika Bhattacharya, Amita Gupta. Hepatotoxicity and Liver-Related Mortality in Women of Childbearing Potential Living With Human Immunodeficiency Virus and High CD4 Cell Counts Initiating Efavirenz-Containing Regimens. Clinical Infectious Diseases. 2021. 72: 1342-1349. PMID: 32161944

Citation

Lee Fairlie, Mauricio Pinilla, Katie McCarthy, Maxensia Owor, Lameck Chinula, Bonus Makanani, Avy Violari, Dhayendre Moodley, Nahida Chakhtoura, Renee Browning, Risa Hoffman, MG Fowler, Gerhard Theron, Sean Brummel. Pregnancy outcomes of women conceiving on antiretroviral therapy (ART) compared to those commenced on ART during pregnancy. Clinical Infectious Diseases. 2021. 73: e312-e320. PMID: 32564058

Citation

Edward P Acosta, Jack Moye, Ellen Townley, Sarah Bradford, Emily Brown, Kayla Denson, Bobbie Graham, Laura Hovind, Thucuma Sise, Hedy Teppler, Sisinyana Ruth Mathiba, Lee Fairlie, Jana L Winckler, Gretchen Slade, Paul Krogstad, Tammy Meyers, Pearl Samson, International Maternal Pediatric Adolescent AIDS Clinical Trials Network P1101 Team. Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis. Journal of Pediatric Infectious Disease Society. 2021. PMID: 32448902